newsfilter
← Latest News
GlobeNewswire·

NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting

GAITHERSBURG, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (NASDAQ:NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of ant